Novel approaches to female sexual dysfunction

被引:13
|
作者
Berman, LA [1 ]
Berman, JR [1 ]
Chhabra, S [1 ]
Goldstein, I [1 ]
机构
[1] Boston Univ, Med Ctr, Div Urol, Boston, MA 02215 USA
关键词
apomorphine; female pelvic anatomy; female sexual disorders; female sexual dysfunction; L-arginine; methyltestosterone; neurogenic mediators; oestrogen; phentolamine; prostaglandin E1; sildenafil; testosterone; yohimbine;
D O I
10.1517/13543784.10.1.85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Female sexual dysfunction is age-related, progressive and highly prevalent, affecting 30 - 50% of American women. While there are emotional and relational elements to sexual function, it has become increasingly evident that female sexual dysfunction can occur secondary to medical problems and has an organic basis. A plethora of different female sexual dysfunctions exist and in order to obtain a greater understanding of the possible treatments for these problems, it is essential to have a strong knowledge base of female pelvic anatomy, the neurogenic mediators of female sexual response, the impact of hormones on female sexual function and the aetiologies of female sexual dysfunction. Currently, there are potential therapeutic options for the treatment of female sexual dysfunction and these options include both hormonal and pharmacological therapy. However, therapeutic agents may not prove to be enough and the ideal approach to female sexual dysfunction is thus a collaborative effort between therapists and physicians, which should include a complete medical and psychosocial evaluation, as well as inclusion of the partner or spouse in the evaluation and treatment process.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 50 条
  • [31] Phosphodiesterase inhibitors in female sexual dysfunction
    Margit Mayer
    Christian G. Stief
    Michael C. Truss
    Stefan Ückert
    World Journal of Urology, 2005, 23 : 393 - 397
  • [32] Female Sexual Dysfunction: Is It a Treatable Disease?
    Houman, Justin
    Feng, Tom
    Eilber, Karyn S.
    Anger, Jennifer T.
    CURRENT UROLOGY REPORTS, 2016, 17 (04) : 1 - 6
  • [33] SEXUAL DYSFUNCTION IN A FEMALE HOSPITAL STAFF
    Demir, Omer
    Parlakay, Nurcan
    Gok, Gulseren
    Esen, Adil Ahmet
    TURKISH JOURNAL OF UROLOGY, 2007, 33 (02): : 156 - 160
  • [34] Evaluation and management of female sexual dysfunction
    Bachmann, GA
    Avci, D
    ENDOCRINOLOGIST, 2004, 14 (06) : 337 - 345
  • [35] Female sexual dysfunction: State of the art
    Anastasiadis A.G.
    Salomon L.
    Ghafar M.A.
    Burchardt M.
    Shabsigh R.
    Current Urology Reports, 2002, 3 (6) : 484 - 491
  • [36] Physiology of female sexual function and dysfunction
    Berman, JR
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (Suppl 1) : S44 - S51
  • [37] Association of mindfulness with female sexual dysfunction
    Sood, Richa
    Kuhle, Carol L.
    Thielen, Jacqueline M.
    Kapoor, Ekta
    Vencill, Jennifer A.
    Mara, Kristin C.
    Faubion, Stephanie S.
    MATURITAS, 2022, 161 : 27 - 32
  • [38] Management of Hypertension with Female Sexual Dysfunction
    Zhong, Qing
    Anderson, Yuri
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [39] Obesity and sexual dysfunction, male and female
    Esposito, K.
    Giugliano, F.
    Ciotola, M.
    De Sio, M.
    D'Armiento, M.
    Giugliano, D.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (04) : 358 - 365
  • [40] Vascular testing in female sexual dysfunction
    John P. Mulhall
    Current Sexual Health Reports, 2004, 1 (1) : 12 - 16